MHC class I on target cells regulates CD4⁺ T cell-mediated immunity

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Major histocompatibility complex (MHC) class I and II molecules present antigens to CD8+ and CD4+ T cells, respectively.
• The established roles of MHC class I involve CD8+ T cell and natural killer cell interactions.

Purpose of the Study:

• To investigate a previously unrecognized function of MHC class I in CD4+ T cell-mediated immunity.
• To explore the impact of MHC class I absence on CD4+ T cell cytotoxicity in disease models.

Main Methods:

• Utilized allogeneic graft-versus-host disease and tumor models.
• Conducted transcriptomic and functional studies.
• Analyzed large human transcriptomic and sequencing datasets.

Main Results:

• Absence of MHC class I on target cells significantly increased susceptibility to CD4+ T cell cytotoxicity.
• Heightened sensitivity to ferroptosis in target cells was identified as a contributing factor.
• Human datasets suggested a role for CD4+ T cells in enhancing immune checkpoint blocker responses in cancers with downregulated MHC class I.

Conclusions:

• MHC class I has a previously unrecognized role in CD4+ T cell-mediated immunity.
• These findings expand the known functions of MHC class I beyond CD8+ T cell and NK cell interactions.
• The study highlights a novel mechanism in cancer and alloimmunity involving CD4+ T cells and MHC class I.